Sodium 2-[(3R)-3-[(2-methylpropan-2-yl)oxycarbonylamino]piperidin-1-yl]pyrimidine-5-carboxylate
C15H21N4NaO4 — CID 172624053
Data last refreshed: (MolForge compound catalog, from PubChem)
About Sodium 2-[(3R)-3-[(2-methylpropan-2-yl)oxycarbonylamino]piperidin-1-yl]pyrimidine-5-carboxylate
Sodium 2-[(3R)-3-[(2-methylpropan-2-yl)oxycarbonylamino]piperidin-1-yl]pyrimidine-5-carboxylate (PubChem CID 172624053) has the molecular formula C15H21N4NaO4 and a molecular weight of 344.35 g/mol. Its IUPAC name is sodium 2-[(3R)-3-[(2-methylpropan-2-yl)oxycarbonylamino]piperidin-1-yl]pyrimidine-5-carboxylate.
Molecular Properties
| Compound Name | Sodium 2-[(3R)-3-[(2-methylpropan-2-yl)oxycarbonylamino]piperidin-1-yl]pyrimidine-5-carboxylate |
|---|---|
| PubChem CID | 172624053 |
| Molecular Formula | C15H21N4NaO4 |
| Molecular Weight | 344.35 g/mol |
| Exact Mass | 344.15 |
| IUPAC Name | sodium 2-[(3R)-3-[(2-methylpropan-2-yl)oxycarbonylamino]piperidin-1-yl]pyrimidine-5-carboxylate |
| SMILES | CC(C)(C)OC(=O)N[C@@H]1CCCN(c2ncc(C(=O)[O-])cn2)C1.[Na+] |
| InChI | InChI=1S/C15H22N4O4.Na/c1-15(2,3)23-14(22)18-11-5-4-6-19(9-11)13-16-7-10(8-17-13)12(20)21;/h7-8,11H,4-6,9H2,1-3H3,(H,18,22)(H,20,21);/q;+1/p-1/t11-;/m1./s1 |
| InChIKey | PAPUWVYWIDXLIA-RFVHGSKJSA-M |
| XLogP | -2.66 |
| TPSA | 107.48 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 344.35 |
| LogP ≤ 5 | -2.66 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 172624053 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.